Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 1999, p. 2430-2436, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Propagation of TEM- and PSE-Type
-Lactamases
among Amoxicillin-Resistant Salmonella spp. Isolated
in France
Catherine
Llanes,1,*
Veronique
Kirchgesner,2 and
Patrick
Plesiat1
Laboratoire de Bactériologie,
Faculté de Médecine, Université de
Franche-Comté, 25030 Besançon,1
and Centre Hospitalier Général Châlon sur
Saône 71000,2 France
Received 5 February 1999/Returned for modification 31 May
1999/Accepted 10 August 1999
 |
ABSTRACT |
A survey conducted between 1987 and 1994 at the University Hospital
of Besançon, France, demonstrated a dramatic increase (from 0 to
42.5%) in the prevalence of amoxicillin resistance among
Salmonella spp. Of the 96 resistant isolates collected
during this period (including 77 Typhimurium), 54 were found to produce TEM-1
-lactamase, 40 produced PSE-1 (equivalent to CARB-2), one produced PSE-1 plus TEM-2, and one produced OXA-1 in isoelectric focusing and DNA hybridization experiments. Plasmids coding for these
-lactamases were further characterized by (i) profile analysis, (ii)
restriction fragmentation pattern analysis, (iii) hybridization with an
spvCD-orfE virulence probe, and (iv) replicon typing. In
addition, isolates of S. typhimurium were genotypically
compared by pulsed-field gel electrophoresis of
XbaI-macrorestricted chromosomal DNA. Altogether, these
methods showed that 40 of the 41 PSE-1 producers were actually the
progeny of a single epidemic S. typhimurium strain lysotype
DT104. Isolates of that strain were found to harbor RepFIC virulence
plasmids with somewhat different restriction profiles, but which all
carried the blaPSE-1 gene. Of these
virulence/resistance plasmids, 15 were transmissible to
Escherichia coli. TEM-1-producing S. typhimurium displayed much greater genotypic and plasmidic diversities, suggesting the acquisition of the
blaTEM-1 gene from multiple bacterial sources
by individual strains. In agreement with this, 32 of the 35 S. typhimurium plasmids encoding TEM-1 were found to be conjugative.
These data show that development of amoxicillin resistance among
Salmonella, especially in serovar Typhimurium, results from
both gene transfers and strain dissemination.
 |
INTRODUCTION |
-Lactam antibiotics are widely
used in the treatment of salmonellosis. Recently, alarming reports have
pointed out the rapid development of resistance to these agents,
involving Salmonella serovars such as Enteritidis (28,
44), Typhimurium (28, 41, 43), Panama (6),
and Typhi (13) in several countries. Clinical strains of
Salmonella spp. producing large-spectrum
-lactamases and
which are resistant to penicillins (44), or
Salmonella spp. producing extended-spectrum
-lactamases
and which are resistant to cephalosporins such as cefotaxime,
ceftazidime, or ceftriaxone (1, 43), have been isolated from
large outbreaks as well as from sporadic cases.
DNA-based typing methods have provided very useful information on the
dissemination of resistant Salmonella to epidemiological investigations (39). On some occasions, the relatedness of R plasmids harbored by strains of various origins could be demonstrated by restriction fragmentation pattern analysis (RFP), allowing a better
understanding of how resistant strains or R factors may propagate
(3, 40, 44). More recently, methods such as random amplified
polymorphic DNA fingerprinting analysis (17),
IS200 fingerprinting (33), ribotyping, and
restriction fragment length polymorphism analysis (24) have
been evaluated and found to be valuable tools for tracing large
outbreaks due to the circulation of single epidemic clones
(45). R plasmid characterization and strain genotyping have,
however, rarely been combined to compare resistant isolates over long
periods of time or to study the diffusion of resistance determinants
among bacterial populations (13, 36).
From 1987 to 1994, we witnessed a tremendous increase in the prevalence
of amoxicillin resistance among the Salmonella spp. isolated
at the University Hospital of Besançon, France. To establish if
such an increase was due to the dissemination of a few resistant clones
in the community or whether it resulted from the acquisition of
resistance determinants from multiple bacterial sources by Salmonella, we carried out the comparison of the R plasmids
harbored by the resistant isolates, as well as the isolates themselves, by applying various typing methods.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
From 1987 to 1994, 489 Salmonella spp. were isolated from blood
cultures (3%), stool samples (87%), blood and stool samples (1%),
urine samples (3%), urine and stool samples (4%), and biopsies (2%)
of patients hospitalized at the University Hospital of Besançon, France. All isolates were biochemically (API 20E strip;
BioMérieux) and serotypically characterized (Sanofi Pasteur).
Cultures were routinely performed at 37°C on Mueller-Hinton (MH) agar
plates (Sanofi Pasteur) or in brain heart (BH) infusion agar (Sanofi Pasteur), supplemented with 300 µg of rifampicin per ml (Sigma) and/or 50 µg of amoxicillin per ml (SmithKline-Beecham), as required. Transferability of amoxicillin resistance was assessed by conjugational matings, with a mutant of Escherichia coli K-12 resistant to
rifampicin as a recipient. Conjugations were carried out in BH infusion
agar for 4 h at 37°C or, alternatively, on 0.45-µm-pore-size
nitrocellulose filters (Millipore) for 18 h at 37°C
(22). Transconjugants were selected on MH agar medium
containing rifampicin and amoxicillin.
Salmonella plasmids.
Plasmids harbored by
Salmonella were extracted by the method of Kieser
(15) and were visualized by electrophoresis in a horizontal
0.8% (wt/vol) agarose gel calibrated with reference plasmids from
E. coli V517 (18). Total plasmid DNA of
Salmonella was purified by the method of Birnboim and Doly
(4), cleaved with EcoRI, BamHI, or
HindIII (Boehringer Mannheim Biochemicals) according to
the manufacturer's recommendations, and subsequently electrophoresed
in a 0.8% (wt/vol) agarose gel.
Hybridization experiments.
DNA probes were prepared from
purified plasmids (Quiagen plasmid kit) by digestion with appropriate
restriction enzymes or by amplification by PCR with oligonucleotide
primers, as specified in Table 1. The DNA
fragments were separated by agarose gel electrophoresis, purified with
the Bio-Rad Prep-a-gene kit, and labelled by random priming (Random
Primed Labelling kit; Boehringer-Mannheim) with [
32P]dCTP. Colony and Southern blot hybridizations
were performed under highly stringent conditions. Plasmids R1
(21), RP1 (11), and RPL11 (16) were
used as positive controls for the identification of TEM-1 (pI = 5.4), TEM-2 (pI = 5.6), and PSE-1 (pI = 5.7)
-lactamases, respectively. Replicon typing allows the classification of plasmids into replicon groups which, in some cases, match incompatibility groups
(7). In this work, we used nine replicon-specific probes, known to be representative of Salmonella plasmids RepFIC,
RepFIIA, RepHI1, RepHI2, RepI1, RepA/C, RepP, RepQ, and RepX (14,
37). Plasmids were individually typed by Southern hybridization.
PCR conditions and DNA sequencing.
The PCR mixtures (25 µl) contained 1 µl of bacterial lysate (obtained by heating
bacterial colonies to 100°C for 15 min) or 25 to 50 ng of purified
DNA, 0.2 U of Taq DNA polymerase (Goldstar; Eurogentec), 1×
PCR Goldstar buffer, 0.3 µM each primer (Table 1), and 0.2 mM each
deoxynucleoside triphosphate. The amplification step was performed for
30 cycles in a Crocodile II thermal cycler (Appligène). Each
amplification cycle consisted of 1 min at 92°C, 2 min at 50°C, and
3 min at 72°C. A final extension was performed at 72°C for 10 min.
PCR products obtained after amplification with the PSE primers were
purified by using the Wizard PCR Preps kit (Promega) and were sequenced
by an ABI 373A automatic sequencer (Perkin-Elmer, Applied Biosystems).
Their nucleotide sequences were analyzed with the GeneStream align
program (22a).
Macrorestriction analysis.
Preparation of whole cell DNA for
pulsed-field gel electrophoresis (PFGE) was as described by Godard et
al. (10). DNA-containing agarose plugs were incubated
overnight in the presence of 50 U of XbaI
(Boehringer-Mannheim) and underwent PFGE as reported previously. The restriction banding patterns of the isolates were compared by means
of the Taxotron package (P. Grimont, Pasteur Institute), using
SmaI restriction fragments of the Staphylococcus
aureus NCTC 8325 genome for intergel calibration. Major
restriction patterns were defined as differing by more than three bands
and with similarity coefficients less than 85%, according to Struelens
et al. (34). The Dice distance coefficient of
macrorestriction analysis was calculated to be 1.
Antibiotic susceptibility.
Routine drug susceptibility tests
were performed by using the agar diffusion method (disks from Sanofi
Pasteur), according to the guidelines of the National Committee for
Clinical Laboratory Standards (23). MICs were determined
more precisely on MH agar plates containing serial twofold dilutions of
the following antibiotics: amoxicillin, amoxicillin-clavulanate
(SmithKline-Beecham), piperacillin, piperacillin-tazobactam
(Wyeth-Lederlé), cefoperazone (Pfizer), cefuroxime
(Glaxo-Wellcome), and cefotaxime (Roussel-Uclaf). An inoculum of
104 bacteria per spot was deposited by a Steers inoculator
(30). Isolates were also screened for resistance to
chloramphenicol (8 µg/ml), streptomycin (16 µg/ml), spectinomycin
(16 µg/ml), tetracycline (8 µg/ml), trimethoprim (2 µg/ml),
sulfadiazine (64 µg/ml), and nalidixic acid (16 µg/ml).
IEF of
-lactamases.
Analytical isoelectric focusing (IEF)
of
-lactamases (19) produced by Salmonella was
performed in precast polyacrylamide gels (Ampholine PAG Plate, pH 4.0 to 6.5 or pH 3.5 to 9.5; Pharmacia Biotech) using an LKB Multiphor 2117 apparatus (Pharmacia), with bacterial suspensions subjected to three
cycles of freezing and thawing (5).
-Lactamase activity
was revealed in gels by spreading 2 ml of a 0.05% (wt/vol) solution of
nitrocefin (Glaxo-Wellcome).
 |
RESULTS |
Antimicrobial resistance of Salmonella.
A dramatic
increase in the prevalence of amoxicillin resistance was observed among
the Salmonella serovars (n = 489) isolated at the University Hospital of Besançon between 1987 (0%) and 1994 (42.5%). Most of the resistant Salmonella isolates
belonged to the serovar Typhimurium (n = 77). Other
Salmonella serovars were each represented by less than seven
resistant isolates: six S. saint-paul, three S. enteritidis, three S. virchow, one S. agona,
one S. blockley, one S. brandenburg, one S. heidelberg, one S. kedougou, one S. wien,
and one Salmonella sp.
As shown in Table 2, most of the
amoxicillin-resistant isolates (74 of 96) were also resistant to
piperacillin (MIC at which 90% of the isolates are inhibited
[MIC90] = 256 µg/ml). All of these isolates, however,
were susceptible to the combination of piperacillin and tazobactam.
Similarly, MICs of amoxicillin (MIC90 = > 2,048 µg/ml) were strongly reduced in the presence of the
-lactamase
inhibitor clavulanic acid (MIC90 = 16 µg/ml), but seven isolates remained resistant to the combination of both drugs. No
resistance to the expanded-spectrum cephalosporin cefotaxime was noted
among the selected isolates.
Characterization of
-lactamases.
As evidenced by IEF and
Southern blot hybridizations with specific nucleic acid probes, 94 of
96 isolates were found to produce a single
-lactamase (54 produced
TEM-1 and 40 produced PSE-1), and 1 of the 96 isolates produced two
enzymes (PSE-1 and TEM-2). All PSE-1 (CARB-2) producers belonged to the
serovar Typhimurium. Direct sequencing of the pse-1 PCR
products from 13 randomly chosen S. typhimurium isolates
revealed that the amplified gene sequences shared 98% (and the derived
amino acid sequence, more than 99%) identity with those of the PSE-1
gene carried by plasmid RPL11 in Pseudomonas aeruginosa
(16). Finally, 1 of the 96 isolates expressed a
-lactamase of pI 7.4, tentatively identified as an OXA-1 enzyme
(33a).
Identification and transferability of R plasmids.
The
resistant isolates were found to individually contain one (n = 38), two (n = 28), three (n = 15), four (n = 10), five (n = 3),
or six (n = 2) plasmids, with molecular lengths ranging from 1 to 82 kb. Conjugational transfer of the amoxicillin resistance phenotype to a recipient E. coli strain was successful in 67 of 96 (70%) of the Salmonella isolates. Most of the
E. coli transconjugants acquired additional resistances to
tetracycline, chloramphenicol, trimethoprim-sulfamethoxazole, neomycin,
streptomycin, spectinomycin, nalidixic acid, and/or nitrofuranes (data
not shown). Hybridization of the transferred plasmids with TEM- and
PSE-type probes after Southern blotting demonstrated that the
-lactamase genes were all carried by plasmids larger than 35 kb (43 to 82 kb).
Identification of virulence plasmids.
Sixty of the 77 (78%)
S. typhimurium isolates and two S. enteritidis
isolates harbored large (48- to 82-kb) plasmids that hybridized
positively with a spvCD-orfE virulence probe after Southern
transfer (Fig. 1). Interestingly, these
virulence plasmids were found in 100% of the Salmonella
spp. isolated from blood and urine samples, and in 50 and 47% of those
obtained from biopsies and stool samples, respectively. Genes
homologous to spvCD-orfE were not detected in serovars other
than Typhimurium and Enteritidis. It should be stressed here that
nearly all of the virulence plasmids (58 of 60) detected in the
S. typhimurium isolates also carried genes coding for PSE-1
(n = 41) or TEM-1 (n = 17)
-lactamase. The two virulence plasmids found in S. enteritidis were demonstrated to determine
-lactam resistance
as well (TEM-1).

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 1.
Identification of the virulence plasmids in
Salmonella typhimurium. (Upper panel) Visualization of
Salmonella plasmids by agarose gel electrophoresis after
extraction by the method of Kieser (15). Lanes 1 and 22, E. coli V517 plasmids used as molecular size standards (kbp
are indicated on the left of the gel); lane 2, plasmid pIP1350
containing the spvCD-orfE virulence determinant was used as
a positive control; lanes 3 to 21, selected virulent
Salmonella isolates S1, S3, S7, S15, S16, S22, S39, S40,
S41, S42, S43, S49, S50, S51, S53, S54, S55, S57, and S58,
respectively. Chromosomal DNA bands (arrow) are seen in each lane.
(Lower panel) Autoradiogram of the plasmids after Southern transfer and
hybridization with the spvCD-orfE probe.
|
|
Replicon typing.
Replicon typing was carried out with probes
specific to RepFIC, RepFIIA, RepHI1, RepHI2, RepI1, RepA/C, RepP, RepQ,
and RepX groups. Eighty-three of the 96 amoxicillin-resistant
Salmonella isolates (86.5%) contained one or several
plasmids hybridizing with at least one of the selected probes. Plasmids
of the RepFIC group or the RepFIC subgroup B (cross-hybridization with
RepFIC and RepI1 probes) were predominant among the isolates
hybridizing with just one probe (59 of 68), especially in S. typhimurium (n = 34). Other replicon groups were
confined in less frequently isolated serovars (e.g., RepP [three
Saint-Paul, one Brandenburg, and one Typhimurium], RepHI2 [one
Kedougou and one Virchow], and RepQ [one Agona and one
Blockley]). Fifteen of 96 strains scored positive with two
(n = 9), three (n = 4), or even four
(n = 2) different replicon probes, while 16 of 96 contained undetermined replicons. No plasmid hybridized with the
RepFIIA, RepHI1, RepA/C, or RepX probes.
Plasmid restriction fragmentation analysis.
Plasmids of the
resistant Salmonella isolates were finally compared on the
basis of the restriction banding patterns produced after digestion with
endonuclease EcoRI, BamHI, or
HindIII. We could thus identify 14 different plasmidic
groups showing unique core fragment patterns and differing from strain
to strain by less than three bands (Fig.
2). The most frequent restriction profile
(RFP I) was present in 25 isolates of S. typhimurium
recovered from 1988 to 1994. All isolates of this group harbored a
RepFIC virulence plasmid encoding a PSE-1
-lactamase (Table
3). Thirteen other plasmid patterns (II
to XIV) grouped four isolates or less each (Tables 3 and
4).

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 2.
Restriction banding patterns of total plasmid DNA from
selected Salmonella isolates. Lanes 1 and 12, DNA marker
fragments (sizes in kbp are indicated on the right edge of the gel);
lanes 2 to 7, BamHI digestion of DNA from isolates S3 and S5
(RFP II), S78 and S80 (RFP I), and S13 and S14 (RFP III); lanes 8 and
9, EcoRI digestion of S16 and S18 (RFP IV); lanes 10 and 11, HindIII digestion of S27 and S28 (RFP V).
|
|
Macrorestriction analysis.
Isolates of the dominating serovar
Typhimurium were analyzed by PFGE in order to study their
genotypic relatedness. XbaI digestions resulted in
approximately 15 fragments in the range of 10 to 675 kbp. A total of 19 different PFGE banding patterns were detected among the 77 isolates
(representative patterns are shown in Fig. 3). With one exception, the 41 isolates
producing PSE-1
-lactamase could be grouped into a unique genotype,
named A. Altogether, patterns C to H grouped 27 TEM-1-producing
isolates, whereas eight isolates showed unique PFGE banding profiles.
The isolate that produced OXA-1
-lactamase showed a particular
genotype named I (Table 3).

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 3.
XbaI macrorestriction patterns of selected
S. typhimurium isolates. Lanes 1 and 8, DNA marker fragments
of S. aureus NCTC 8325 (sizes in kbp are indicated on the
left of the gel); lanes 2 to 5, pulsotypes F (isolates S88, S16, S18,
and S23); lanes 6, 7, 11, and 12, unrelated pulsotypes (S82, S22, S72,
and S5); lanes 9 and 10, pulsotypes C (S41 and S51).
|
|
 |
DISCUSSION |
The dramatic increase in
-lactam resistance observed during the
survey essentially concerned S. typhimurium (77 of 96 isolates), the most prevalent serovar isolated in our hospital (38%).
In comparison, S. enteritidis, the second most prevalent
serovar (26%), was only rarely resistant to amoxicillin (3 of 96 isolates). Analysis of the resistant S. typhimurium isolates
by using various typing methods allowed the identification of two
distinct groups of isolates, one producing PSE-1
-lactamase and one
producing TEM-1 enzyme (Table 3).
The PSE-1 group consisted of 40 isolates exhibiting very similar PFGE
patterns, showing an identical resistance phenotype (Apr
Cmr Spr Smr Sur
Tcr), and belonging to the DT104 phage type (as determined
from five randomly chosen isolates) (data not presented). These results strongly suggest that all the PSE-1 producers (except one that displayed a unique PFGE profile) actually are the progeny of a single
epidemic strain that spread through France beginning in 1988. The
observation that all these bacteria shared the rather unusual feature
of having RepFIC virulence plasmids carrying the blaPSE-1 gene reinforces this hypothesis. This
is also consistent with recent epidemiological data indicating that
multiresistant DT104 S. typhimurium is increasing in
incidence worldwide mostly because of the transmission of the pathogens
from cattle to humans via food (27).
While our isolates appeared to be closely related with respect to the
markers cited above, their RepFIC virulence/resistance plasmids showed
a somewhat greater diversity. Differences in the size and
transferability of the plasmids were indeed noted among the isolates.
Furthermore, restriction banding pattern analysis demonstrated major
differences between some of the RepFIC virulence/resistance replicons
in bacteria harboring single plasmids (as shown by the different
plasmidic groups in Table 3). This tends to indicate that variations
occurred in the RepFIC virulence/resistance plasmid of the DT104
epidemic strain over time. In support of this speculation, it has been
shown that Salmonella plasmids are frequently subjected to
molecular rearrangements by homologous or illegitimate recombinations (37). Although the plasmidic profile analysis has been
described as a useful epidemiological tool for the differentiation of
epidemic from nonepidemic strains of Salmonella in outbreaks
(39), this marker appears to be inappropriate to ascertain
the epidemiological relatedness of strains isolated over long periods
of time.
DT104 isolates resistant to amoxicillin by production of PSE-1
-lactamase have been reported to be involved in large outbreaks (9, 41). In contrast to the DT104 epidemic strain isolated in our hospital, French, Danish, and British isolates were found to
contain the blaPSE-1 gene integrated into the
bacterial chromosome (26, 29, 32). In these latter strains,
the blaPSE-1 and aadA2 genes
(encoding streptomycin and spectinomycin resistance, respectively) were
present on two distinct integrons, while the genetic determinants
responsible for chloramphenicol and tetracycline resistance were
suspected to reside on transposons. As shown by conjugational transfers
(in 15 of 41 isolates), the RepFIC virulence/resistance plasmids
characterized in this work confered multiresistance to chloramphenicol,
spectinomycin, streptomycin, sulfadiazine, and tetracycline, in
addition to
-lactam resistance. Therefore, it is tempting to assume
that the plasmidic genes that determine these resistances are carried
by integrons and/or transposons able to jump from the chromosome to
resident plasmids and vice versa (29). There is increasing
evidence that integrons are responsible for the acquisition and
dissemination of resistance genes among Salmonella serovars
through plasmid transfers. According to Tosini et al. (42),
RepFI (including RepFIC) plasmids are frequent vehicles of class 1 integrons, which possibly explains their molecular evolution. The fact
that the virulence plasmid of S. typhimurium may serve as a
carrier for resistance genes is, however, unprecedented in DT104
isolates. The implications of this finding are not clear, but this
finding raises the question of what role antibiotics play as selective
agents in the possible dissemination of such virulence/resistance
plasmids among gram-negative enteric bacteria. Interestingly, the
locations of resistance genes on virulence plasmids in S. typhimurium isolate phage type 193 (40) and
Shigella dysenteriae type 1 have recently been described (8).
The bacterial reservoir of the blaPSE-1 gene
(equivalent to blaCARB-2) also remains unclear,
since PSE-1/CARB-2 producers are infrequently encountered among enteric
gram-negative bacteria such as E. coli (38) and
Shigella sp. (20), in contrast to P. aeruginosa (2). Our sequencing results demonstrate that the
-lactamase gene carried by the RepFIC virulence/resistance plasmids of S. typhimurium is highly homologous to that
previously detected in P. aeruginosa plasmid RPL11. Possible
transfers of plasmids between Salmonella serovars and
P. aeruginosa must be confirmed, since these species do not
occur in similar ecological niches (20).
The second group of amoxicillin-resistant S. typhimurium
isolates (n = 54) produced TEM-1 enzyme. In striking
contrast to the PSE-1-producing isolates, members of the TEM-1 group
showed a great genomic diversity when examined by PFGE (Table 3).
Furthermore, the blaTEM-1 gene was detected on
transferable plasmids (in 32 of 35 isolates) with dissimilar phenotypic
and genotypic features. The transferability of R plasmids coding for
TEM-1
-lactamase was also a common feature for amoxicillin-resistant
Salmonella other than S. typhimurium (17 of 19)
(Table 4). The observation that TEM-1
-lactamase is met with
increasing frequencies in other gram-negative enteric species, such as
E. coli (31), suggests that Salmonella
may inherit the blaTEM-1 gene from the
intestinal flora of humans (25) or animals. Indeed,
transfers of amoxicillin resistance between S. enteritidis
and E. coli have recently been demonstrated to occur in vivo
(3).
Altogether, our results reinforce the notion that Salmonella
serovars may efficiently acquire
-lactamase genes from various bacterial sources and that the increasing prevalence of amoxicillin resistance in these bacteria is part of a global trend that involves many other gram-negative species producing TEM-1 enzyme. In contrast, the development of
-lactam resistance due to the production of PSE-1
enzyme results from the dissemination of a few epidemic clones into the population.
 |
ACKNOWLEDGMENTS |
We thank D. Sirot (Faculté de Médecine,
Clermont-Ferrand, France) for help in the identification of OXA-1
-lactamase and F. Grimont (Unité des
Entérobactéries, Institut Pasteur, Paris, France) for
performing phage typing analysis of PSE-1 Salmonella isolates. We also thank T. Köhler and J.-C. Pechere (Centre
Médical Universitaire, Geneva, Switzerland) for critical reading
of the manuscript. We are grateful to Linda Bouchaour and Sandra Tasik for technical assistance. The DNA sequencing was performed at the
Institut d'Etude et de Transfert de Gènes (Besançon, France).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Bactériologie, Hôpital Jean Minjoz, 25030 Besançon,
France. Phone: (33)-81-66-82-86. Fax: (33)-81-66-89-14. E-mail:
patrick.plesiat{at}ufc-chu.univ-fcomte.fr.
 |
REFERENCES |
| 1.
|
Archambaud, M.,
G. Gerbaud,
E. Labau,
N. Marty, and P. Courvalin.
1991.
Possible in-vivo transfer of -lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou.
J. Antimicrob. Chemother.
27:427-436[Abstract/Free Full Text].
|
| 2.
|
Arlet, G., and A. Philippon.
1991.
Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable -lactamases (TEM, SHV, CARB).
FEMS Microbiol. Lett.
82:19-26.
|
| 3.
|
Balis, E.,
A. C. Vatopoulos,
M. Kanelopoulou,
E. Mainas,
G. Hatzoudis,
V. Kontogianni,
H. Malamou-Lada,
S. Kitsou-Kiriakopoulou, and V. Kalapothaki.
1996.
Indications of in vivo transfer of an epidemic R plasmid from Salmonella enteritidis to Escherichia coli to the normal human gut flora.
J. Clin. Microbiol.
34:977-979[Abstract].
|
| 4.
|
Birnboim, H. C., and J. Doly.
1979.
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res.
7:1513-1523[Abstract/Free Full Text].
|
| 5.
|
Bush, K., and R. B. Sykes.
1986.
Methodology for the study of -lactamases.
Antimicrob. Agents Chemother.
30:6-10[Free Full Text].
|
| 6.
|
Cornado, A. M., and R. Virgilio.
1996.
Evolution of drug resistance in Salmonella panama isolates in Chile.
Antimicrob. Agents Chemother.
40:336-341[Abstract].
|
| 7.
|
Couturier, M.,
F. Bex,
P. L. Bergquist, and W. K. Maas.
1988.
Identification and classification of bacterial plasmids.
Microbiol. Rev.
52:375-395[Free Full Text].
|
| 8.
|
Datta, S.,
A. Pal,
S. Basu, and P. C. Banerjee.
1997.
Involvement of a 70-kb plasmid of the epidemic Shigella dysenteriae type 1 (Dt66) strain in drug-resistance, lipopolysaccharide synthesis, and virulence.
Microb. Drug Resist.
3:351-357.
[Medline] |
| 9.
|
Glynn, M. K.,
C. Bopp,
W. Dewitt,
P. Dabney,
M. Mokhtar, and F. J. Angulo.
1998.
Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.
N. Engl. J. Med.
338:1333-1338[Abstract/Free Full Text].
|
| 10.
|
Godard, C.,
P. Plésiat, and Y. Michel-Briand.
1993.
Persistance of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.
Eur. J. Med.
2:117-120[Medline].
|
| 11.
|
Grinsted, J.,
J. R. Saunders,
L. C. Ingram,
R. B. Sykes, and M. H. Richmond.
1972.
Properties of an R factor which originated in Pseudomonas aeruginosa 1822.
J. Bacteriol.
110:529-537[Abstract/Free Full Text].
|
| 12.
|
Gulig, P. A.,
H. Danbara,
D. G. Guiney,
A. J. Lax,
F. Norel, and M. Rhen.
1993.
Molecular analysis of spv virulence genes of the Salmonella virulence plasmids.
Mol. Microbiol.
7:825-830[Medline].
|
| 13.
|
Hermans, P. W. M.,
S. K. Saha,
W. J. van Leeuwen,
H. A. Verbrugh,
A. van Belkum, and W. H. F. Goessens.
1996.
Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates.
J. Clin. Microbiol.
43:1373-1379.
|
| 14.
|
Jones, C., and J. Stanley.
1992.
Salmonella plasmids of the pre-antibiotic era.
J. Gen. Microbiol.
138:189-197[Abstract/Free Full Text].
|
| 15.
|
Kieser, T.
1984.
Factors affecting the isolation of cccDNA from Streptomyces lividans and Escherichia coli.
Plasmid
12:19-36[Medline].
|
| 16.
|
Korfhagen, T. R., and J. C. Loper.
1975.
RPL11, an R factor of Pseudomonas aeruginosa determining carbenicillin and gentamicin resistance.
Antimicrob. Agents Chemother.
7:69-73[Abstract/Free Full Text].
|
| 17.
|
Lin, A. W.,
M. A. Usera,
T. J. Barrett, and R. A. Goldsby.
1996.
Application of random amplified polymorphic DNA analysis to differentiate strains of Salmonella enteritidis.
J. Clin. Microbiol.
34:870-876[Abstract].
|
| 18.
|
Macrina, F. L.,
D. J. Kopecko,
K. R. Jones,
D. J. Ayers, and S. M. MacCowen.
1978.
A multiple plasmid containing Escherichia coli strain: convenient source of size reference plasmid molecules.
Plasmid
1:417-420[Medline].
|
| 19.
|
Matthew, M.,
A. M. Harris,
M. J. Mashall, and G. W. Ross.
1975.
The use of analytical isoelectric focusing for detection and identification of -lactamases.
J. Gen. Microbiol.
88:169-178[Medline].
|
| 20.
|
Medeiros, A. A.,
R. W. Hedge, and G. A. Jacoby.
1982.
Spread of a Pseudomonas-specific -lactamase to plasmids of enterobacteria.
J. Bacteriol.
149:700-707[Abstract/Free Full Text].
|
| 21.
|
Meynell, E., and N. Datta.
1966.
The relation of resistance transfer factors to the F factor (sex factor) of E. coli K12.
Genet. Res.
7:134-140[Medline].
|
| 22.
|
Michel-Briand, Y.,
M.-J. Dupont,
I. Chardon-Loriaux, and M. Jouvenot.
1981.
Isolation of an antibiotic multiresistance plasmid from Pseudomonas aeruginosa.
J. Antimicrob. Chemother.
7:371-378[Abstract/Free Full Text].
|
| 22a.
|
National Center for Biotechnology.
24 November 1997.
posting date. [Online.] GeneStream align program.
http://vega.igh.cnrs.fr. [3 April 1998, last date accessed.]
|
| 23.
|
National Committee for Clinical Laboratory Standards.
1994.
Zone diameter interpretive standards and equivalent minimum inhibitory concentration. Standard M100-S5, table M2-A5.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 24.
|
Navarro, F.,
T. Llovet,
M. A. Echeita,
P. Coll,
A. Aladuena,
M. A. Usera, and G. Prats.
1996.
Molecular typing of Salmonella enterica serovar typhi.
J. Clin. Microbiol.
34:2831-2834[Abstract].
|
| 25.
|
Platt, D. J.,
J. S. Sommerville, and J. Gribben.
1984.
Sequential acquisition of R-plasmids in vivo by Salmonella typhimurium.
J. Antimicrob. Chemother.
13:65-69[Abstract/Free Full Text].
|
| 26.
|
Poirel, L.,
M. Guibert,
S. Bellais,
T. Naas, and P. Nordmann.
1999.
Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 from French patients.
Antimicrob. Agents Chemother.
43:1098-1104[Abstract/Free Full Text].
|
| 27.
|
Poppe, C.,
N. Smart,
R. Khakhria,
W. Johnson,
J. Spika, and J. Prescott.
1998.
Salmonella typhimurium DT104: a virulent and drug-resistant pathogen.
Can. Vet. J.
39:559-565[Medline].
|
| 28.
|
Ramos, J. M.,
J. M. Alés,
M. Cuenca-Estrella,
R. Fernandez-Roblas, and F. Soriano.
1996.
Changes in susceptibility of Salmonella enteritidis, Salmonella typhimurium and Salmonella virchow to six antimicrobial agents in a Spanish hospital.
Eur. J. Clin. Microbiol. Infect. Dis.
15:85-88[Medline].
|
| 29.
|
Ridley, A., and E. J. Threlfall.
1998.
Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT104.
Microb. Drug Resist.
4:113-118.
[Medline] |
| 30.
|
Sahm, D. F., and J. A. Washington, II.
1991.
Antibacterial susceptibility tests: dilution methods, p. 1105-1116.
In
A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
|
| 31.
|
Sanders, C. C., and E. Sanders, Jr.
1992.
-Lactam resistance in gram-negative bacteria: global trends and clinical impact.
Clin. Infect. Dis.
15:824-839[Medline].
|
| 32.
|
Sandvang, D.,
F. M. Aarestrup, and L. B. Jensen.
1998.
Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica typhimurium DT104.
FEMS Microbiol. Lett.
160:37-41[Medline].
|
| 33.
|
Schiaffino, A.,
C. R. Beuzon,
S. Uzzau,
G. Leori,
P. Cappuccinelli,
J. Casadesus, and S. Rubino.
1996.
Strain typing with IS200 fingerprints in Salmonella abortusovis.
Appl. Environ. Microbiol.
62:2375-2380[Abstract].
|
| 33a.
| Sirot, D. Personal communication.
|
| 34.
|
Struelens, M. J.,
A. Deplano,
C. Godard,
N. Maes, and E. Serruys.
1992.
Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by pulsed-field gel electrophoresis.
J. Clin. Microbiol.
30:2599-2605[Abstract/Free Full Text].
|
| 35.
|
Sutcliffe, J. G.
1978.
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.
Proc. Natl. Acad. Sci. USA
75:3737-3741[Abstract/Free Full Text].
|
| 36.
|
Tassios, P. T.,
A. Markogiannakis,
A. C. Vatopoulos,
E. Katsanikou,
E. N. Velonakis,
J. Kourea-Kremastinou, and N. J. Legakis.
1997.
Molecular epidemiology of antibiotic resistance of Salmonella enteritidis during a 7-year period in Greece.
J. Clin. Microbiol.
35:1316-1321[Abstract].
|
| 37.
|
Taylor, D. E.,
J. C. Chumpitaz, and F. Goldstein.
1985.
Variability of IncHI1 plasmids from Salmonella typhi with special reference to Peruvian plasmids encoding resistance to trimethoprim and other antibiotics.
Antimicrob. Agents Chemother.
28:452-455[Abstract/Free Full Text].
|
| 38.
|
Thomson, K. S.,
D. A. Weber,
C. C. Sanders, and W. E. Sanders, Jr.
1990.
-Lactamase production in members of the family Enterobacteriaceae and resistance to -lactam-enzyme inhibitor combinations.
Antimicrob. Agents Chemother.
34:622-627[Abstract/Free Full Text].
|
| 39.
|
Threlfall, E. J., and J. A. Frost.
1990.
The identification, typing and fingerprinting of Salmonella: laboratory aspects and epidemiological applications.
J. Appl. Bacteriol.
68:5-16[Medline].
|
| 40.
|
Threlfall, E. J.,
M. D. Hampton,
H. Chart, and B. Rowe.
1994.
Identification of a conjugative plasmid carrying antibiotic resistance and Salmonella plasmid virulence (spv) genes in epidemic strains of Salmonella typhimurium phage type 193.
Lett. Appl. Microbiol.
18:82-85.
|
| 41.
|
Threlfall, E. J.,
L. R. Ward,
J. A. Skinner, and B. Rowe.
1997.
Increase in multiple antibiotic resistance in nontyphoidal Salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996.
Microb. Drug Resist.
3:263-266.
[Medline] |
| 42.
|
Tosini, F.,
P. Visca,
I. Luzzi,
A.-M. Dionisi,
C. Pezzella,
A. Petrucca, and A. Carattoli.
1998.
Class 1 integron-borne multiple-antibiotic resistance carried by Inc/FI and Inc/L/M plasmids in Salmonella enterica serotype Typhimurium.
Antimicrob. Agents Chemother.
42:3053-3058[Abstract/Free Full Text].
|
| 43.
|
Vahaboglu, H.,
L. M. C. Hall,
L. Mulazimoglu,
S. Dodanli,
I. Yildirim, and D. M. Livermore.
1995.
Resistance to extended-spectrum cephalosporins, caused by PER-1 -lactamase, in Salmonella typhimurium from Istanbul, Turkey.
J. Med. Microbiol.
43:294-299[Abstract/Free Full Text].
|
| 44.
|
Vatopoulos, A. C.,
E. Mainas,
E. Balis,
E. J. Threlfall,
M. Kanelopoulou,
V. Kalapothaki,
H. Malamou-Lada, and N. J. Rowe.
1994.
Molecular epidemiology of ampicillin-resistant clinical isolates of Salmonella enteritidis.
J. Clin. Microbiol.
32:1322-1325[Abstract/Free Full Text].
|
| 45.
|
Wegener, H. C., and D. L. Baggesen.
1996.
Investigation of an outbreak of human salmonellosis caused by Salmonella enterica ssp. enterica serovar Infantis by use of pulsed field gel electrophoresis.
Int. J. Food Microbiol.
32:125-131[Medline].
|
Antimicrobial Agents and Chemotherapy, October 1999, p. 2430-2436, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Foley, S. L., Lynne, A. M.
(2008). Food animal-associated Salmonella challenges: Pathogenicity and antimicrobial resistance. J ANIM SCI
86: E173-E187
[Abstract]
[Full Text]
-
Villa, L., Carattoli, A.
(2005). Integrons and Transposons on the Salmonella enterica Serovar Typhimurium Virulence Plasmid. Antimicrob. Agents Chemother.
49: 1194-1197
[Abstract]
[Full Text]
-
Chiu, C.-H., Su, L.-H., Chu, C.
(2004). Salmonella enterica Serotype Choleraesuis: Epidemiology, Pathogenesis, Clinical Disease, and Treatment. Clin. Microbiol. Rev.
17: 311-322
[Abstract]
[Full Text]
-
Orman, B. E., Pineiro, S. A., Arduino, S., Galas, M., Melano, R., Caffer, M. I., Sordelli, D. O., Centron, D.
(2002). Evolution of Multiresistance in Nontyphoid Salmonella Serovars from 1984 to 1998 in Argentina. Antimicrob. Agents Chemother.
46: 3963-3970
[Abstract]
[Full Text]
-
Guerra, B., Soto, S., Helmuth, R., Mendoza, M. C.
(2002). Characterization of a Self-Transferable Plasmid from Salmonella enterica Serotype Typhimurium Clinical Isolates Carrying Two Integron-Borne Gene Cassettes Together with Virulence and Drug Resistance Genes. Antimicrob. Agents Chemother.
46: 2977-2981
[Abstract]
[Full Text]
-
Chiu, C.-H., Chu, C., Su, L.-H., Wu, W.-Y., Wu, T.-L.
(2002). Characterization of a Laboratory-Derived, High-Level Ampicillin-Resistant Salmonella enterica Serovar Typhimurium Strain That Caused Meningitis in an Infant. Antimicrob. Agents Chemother.
46: 1604-1606
[Abstract]
[Full Text]
-
Chu, C., Chiu, C.-H., Wu, W.-Y., Chu, C.-H., Liu, T.-P., Ou, J. T.
(2001). Large Drug Resistance Virulence Plasmids of Clinical Isolates of Salmonella enterica Serovar Choleraesuis. Antimicrob. Agents Chemother.
45: 2299-2303
[Abstract]
[Full Text]
-
Breuil, J., Brisabois, A., Casin, I., Armand-Lefevre, L., Fremy, S., Collatz, E.
(2000). Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. J Antimicrob Chemother
46: 965-971
[Abstract]
[Full Text]
-
Guerra, B., Soto, S., Cal, S., Mendoza, M. C.
(2000). Antimicrobial Resistance and Spread of Class 1 Integrons among Salmonella Serotypes. Antimicrob. Agents Chemother.
44: 2166-2169
[Abstract]
[Full Text]